| Literature DB >> 35278200 |
M Visser1, N Mendonça2,3, C Avgerinou4, T Cederholm5, A J Cruz-Jentoft6, S Goisser7, E Kiesswetter8, H M Siebentritt8, D Volkert8, G Torbahn8,9.
Abstract
PURPOSE: To conduct a scoping review to provide a systematic overview of outcomes used in nutritional intervention studies focused on the treatment of protein-energy malnutrition in older adults.Entities:
Keywords: Aging; Dietary counselling; ONS; Undernutrition
Mesh:
Year: 2022 PMID: 35278200 PMCID: PMC9378339 DOI: 10.1007/s41999-022-00617-5
Source DB: PubMed Journal: Eur Geriatr Med ISSN: 1878-7649 Impact factor: 3.269
Main characteristics of the 60 included nutritional intervention RCTs to treat protein-energy malnutrition in older adults
| Characteristic | Categories | Number of RCTs (%) |
|---|---|---|
| Publication year | ≤ 2000 | 4 (7%) |
| 2001–2010 | 19 (32%) | |
| 2011–2020 | 37 (61%) | |
| Continent | Europe | 40 (67%) |
| Asia | 9 (15%) | |
| North America | 8 (13%) | |
| Australia | 3 (5%) | |
| Publication type | Results paper | 50 (83%) |
| Protocol paper | 9 (15%) | |
| Trial registration | 1 (2%) | |
| Setting | Community1 | 26 (43%) |
| Hospital | 13 (22%) | |
| Long-term care | 13 (22%) | |
| Mixed | 7 (11%) | |
| NR | 1 (2%) | |
| Sample type | General | 41 (68%) |
| Specific patient group | 18 (30%) | |
| NR | 1 (2%) | |
| Sample size ( | ≤ 50 | 14 (23%) |
| 51–100 | 20 (33%) | |
| 101–200 | 21 (35%) | |
| 200 + | 4 (7%) | |
| NR | 1 (2%) | |
| Age (y) | 65 + or > 65 | 37 (62%) |
| 70 + or > 70 | 9 (15%) | |
| Other | 14 (23%) | |
| Malnutrition status | At risk of malnutrition only | 16 (27%) |
| Malnourished only | 4 (7%) | |
| Combination | 40 (66%) | |
| Intervention type | ONS | 32 (54%) |
| Dietary counselling | 15 (25%) | |
| Dietary counselling + ONS | 9 (15%) | |
| Protein supplement | 2 (3%) | |
| Other | 2 (3%) | |
| Control | Usual care | 37 (62%) |
| Placebo ONS | 5 (8%) | |
| Different type of ONS | 5 (8%) | |
| Dietary counselling | 4 (7%) | |
| Written information | 4 (7%) | |
| Home visit(s) | 5 (8%) | |
| Intervention duration (w) | ≤ 8 | 16 (27%) |
| 9–12 | 20 (33%) | |
| 13–26 | 11 (18%) | |
| 27–52 | 2 (3%) | |
| > 52 | 0 (0%) | |
| Other2 | 4 (7%) | |
| NR | 7 (12%) | |
| Follow-up duration (w) | ≤ 8 | 9 (15%) |
| 9–12 | 25 (42%) | |
| 13–26 | 14 (23%) | |
| 27–52 | 8 (13%) | |
| > 52 | 2 (3%) | |
| Other | 1 (2%) | |
| NR | 1 (2%) | |
| Study funding | Government and/or university | 27 (45%) |
| Government and/or university, with supplements provided by industry | 3 (5%) | |
| (Co)funding by industry (and supplements provided by industry) | 15 (25%) | |
| (Co)funding by industry and industry employee is (co)author | 9 (15%) | |
| NR | 6 (10%) |
NR not reported. ONS Oral Nutritional Supplement. Y years, w weeks
1Of which n = 11 just after hospital discharge, and n = 3 with home care
2Until hospital discharge or during chemotherapy treatment
Fig. 1Flowchart
Fig. 2Frequency of the outcomes and outcome domains reported in at least two randomized controlled trials
Top ten of most frequently used outcomes and outcome domains per setting
| Community ( | Hospital ( | Long-term care ( | Mixed or not reported ( | |
|---|---|---|---|---|
| 1 | Body weight/BMI ( | Body weight/BMI ( | Body weight/BMI ( | Functional limitation ( |
| 2 | Dietary intake ( | Body circumference ( | Dietary intake ( | Body weight/BMI ( |
| 3 | Handgrip strength ( | Dietary intake ( | Malnutrition status ( | Malnutrition status ( |
| 4 | Functional limitation ( | Hangrip strength ( | Handgrip strength ( | Blood marker ( |
| 5 | Functional performance ( | Malnutrition status ( | Body circumference ( | Re (hospitalization) ( |
| 6 | Body circumference ( | Functional performance ( | Functional limitation ( | Dietary intake ( |
| 7 | (Re) hospitalization ( | Muscle mass ( | Blood marker ( | Mortality ( |
| 8 | Quality of life ( | Length of stay ( | Quality of life ( | Handgrip strength ( |
| 9 | Blood marker ( | Skinfolds ( | Appetite ( | Muscle mass ( |
| 10 | Malnutrition status ( | Functional limitation ( | Functional performance ( | Cognition ( |
Fifty-five out of the 60 RCTs had more than one outcome and therefore percentages add to more than 100% by setting
BMI body mass index
Overview and frequency of specific variables included in the three outcome domains: body circumference, blood marker and skinfold
| Domain | Methodology | Number of RCTs |
|---|---|---|
| Body circumference ( | Mid-upper arm (MUAC) | 19 |
| Calf | 11 | |
| Thigh | 1 | |
| Blood marker1 ( | Albumin | 11 |
| C-reactive protein (CRP) | 7 | |
| Total cholesterol | 7 | |
| Pre-albumin | 5 | |
| Haemoglobin | 5 | |
| Vitamin D (25(OH)D) | 5 | |
| Transferrin | 4 | |
| Insulin-like growth factor-I (IGF-I) | 4 | |
| Lymphocyte count | 4 | |
| LDL cholesterol | 4 | |
| Total Blood cell count | 3 | |
| HDL cholesterol | 3 | |
| Haematocrit | 3 | |
| Triglycerides | 3 | |
| White blood cell count (WBC) | 2 | |
| Prognostic inflammatory nutritional index (PINI) | 2 | |
| Electrolytes | 2 | |
| Creatinine | 2 | |
| Calcium | 2 | |
| Fasting glucose | 2 | |
| Vitamin B12 | 2 | |
| Folic acid | 2 | |
| Zinc | 2 | |
| Skinfold ( | Triceps | 9 |
| Sub-scapula | 2 | |
| Supra-iliac | 1 | |
| Abdominal | 1 |
LDL low-density lipoprotein; HDL high-density lipoprotein
1Only blood markers that were assessed at least in two RCTs are included in the table. All included blood markers can be found in table S3
Overview and frequency of the methodology used to assess outcomes
| Outcome | Methodology | Number of RCTs |
|---|---|---|
| Dietary intake ( | Dietary records | 12 |
| 24-h dietary recalls | 11 | |
| 24-h dietary recalls or dietary records | 2 | |
| Food-frequency questionnaire | 3 | |
| Other (i.e., percentage of serving consumed, registration form, food intake protocol, 3-day count, and food chart) | 5 | |
| Not specified | 4 | |
| Handgrip strength ( | JAMAR dynamometer | 5 |
| Takei dynamometer | 4 | |
| Martin vigorimeter | 3 | |
| Smedley hand dynamometer | 2 | |
| Harpenden dynamometer | 1 | |
| Digimax dynamometer | 1 | |
| MSD dynamometer | 1 | |
| Tanita dynamometer | 1 | |
| Vital sign TM dynamometer | 1 | |
| SAEHAN dynamometer | 1 | |
| Not specified | 7 | |
| Functional limitation ( | Barthel Activities of daily living (ADL) index | 17 |
| Katz index of Independence in ADL | 2 | |
| Morton Mobility Index (DEMMI) | 2 | |
| Lawton Instrumental ADL (IADL) scale | 2 | |
| Avlund mobility-tiredness scale (Mob-T) | 2 | |
| Self-reported Disability Score | 1 | |
| Functional Independence Measure (FIM) | 1 | |
| Functional Assessment Screening Tool (FAST) | 1 | |
| Consumer Assessments Study Interview Battery (CAS) | 1 | |
| Not specified | 3 | |
| Malnutrition status ( | Mini Nutritional Assessment (MNA) | 13 |
| Mini Nutritional Assessment Short-Form (MNA-SF) | 6 | |
| Malnutrition Universal Screening Tool (MUST) | 1 | |
| Subjective Global Assessment (SGA) | 1 | |
| DETERMINE | 1 | |
| Not specified | 2 | |
| Functional performance ( | Gait speed | 7 |
| Timed Up and Go (TUG) | 6 | |
| Short Physical Performance Battery (SPPB) | 5 | |
| 30 s chair stands | 5 | |
| 1-leg stand | 1 | |
| Quality of life ( | 36-item Short Form Health Survey (SF-36) | 7 |
| EuroQol (EQ-5D) | 5 | |
| QUALIDEM | 1 | |
| Dartmouth Primary Care Cooperative Information chart (COOP) | 1 | |
| Not specified | 3 | |
| Muscle mass ( | Dual-energy X-ray absorptiometry (DXA) | 8 |
| Bio-electrical impedance / bio-impedance spectroscopy | 6 | |
| Anthropometry (combination of mid-upper arm circumference and skinfold to derive muscle circumference) | 3 | |
| Deuterium oxide dilution | 1 | |
| Not specified | 1 |